NCT04071613View on ClinicalTrials.gov

Tenecteplase Versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance

PHASE2CompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

June 20, 2019

Primary Completion Date

November 16, 2021

Study Completion Date

November 16, 2021

Conditions
Stroke, Acute, Stroke Ischemic
Interventions
DRUG

Tenecteplase

Route: IV bolus injection Frequency: once only, within 4.5 hours of stroke onset

DRUG

Intravenous tissue plasminogen activator (tPA)

Route: Intravenous (IV) infusion (10% as bolus and the remainder over 60 minutes) Frequency: once only, within 4.5 hours of stroke onset

Trial Locations (5)

3050

Royal Melbourne Hospital, Melbourne

Unknown

Eastern Health, Melbourne

Western Hospital, Melbourne

Alfred Hopsital, Melbourne

Monash Health, Melbourne

Sponsors

Lead Sponsor

Melbourne Health
All Listed Sponsors
lead

Melbourne Health

OTHER